BR9707953A - Derivados de mercapto como inibidores de ciclooxigenases - Google Patents
Derivados de mercapto como inibidores de ciclooxigenasesInfo
- Publication number
- BR9707953A BR9707953A BR9707953-7A BR9707953A BR9707953A BR 9707953 A BR9707953 A BR 9707953A BR 9707953 A BR9707953 A BR 9707953A BR 9707953 A BR9707953 A BR 9707953A
- Authority
- BR
- Brazil
- Prior art keywords
- mercapto
- cyclooxygenase inhibitors
- mammal
- mercapto derivatives
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
<B>DERIVADOS DE MERCAPTO COMO INIBIDORES DE CICLOOXIGENASES<D> A presente invenção é dirigida a uma composição farmacologicamente aceitável para inibir ciclooxigenase em um mamífero, que inclui um derivado de mercapto e um veículo farmaceuticamente aceitável. A invenção também se refere a um processo de inibir ciclooxigenase e tratar várias condições onde haja vantagem em inibir biossíntese de prostaglandinas. O processo inclui a etapa de administrar a um mamífero um derivado de mercapto em forma pura ou em um veículo farmaceuticamente aceitável.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61109796A | 1996-03-05 | 1996-03-05 | |
PCT/US1997/003279 WO1997032575A1 (en) | 1996-03-05 | 1997-03-03 | Mercapto derivatives as inhibitors of cyclooxygenases |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9707953A true BR9707953A (pt) | 2000-10-24 |
Family
ID=24447614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9707953-7A BR9707953A (pt) | 1996-03-05 | 1997-03-03 | Derivados de mercapto como inibidores de ciclooxigenases |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2000506852A (pt) |
CN (1) | CN1212620A (pt) |
AU (1) | AU2063397A (pt) |
BR (1) | BR9707953A (pt) |
TR (1) | TR199801731T2 (pt) |
WO (1) | WO1997032575A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001520174A (ja) * | 1997-10-22 | 2001-10-30 | メルク エンド カムパニー インコーポレーテッド | 心血管疾患および脳血管疾患に関するリスクを低下させる併用療法 |
CH700523A1 (de) * | 2009-03-09 | 2010-09-15 | Markus Luethy | Neue Hautaufheller. |
RS63063B1 (sr) | 2010-08-19 | 2022-04-29 | Zoetis Belgium S A | Anti-ngf antitela i njihova upotreba |
KR101178947B1 (ko) * | 2011-04-29 | 2012-09-03 | 한국생명공학연구원 | 올레아놀린산 아세테이트를 유효성분으로 포함하는 tlr 및 il-6 매개성 질환 예방 또는 치료용 약학적 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246971A (en) * | 1991-12-16 | 1993-09-21 | Washington University | Method of inhibiting nitric oxide formation |
GB9200114D0 (en) * | 1992-01-04 | 1992-02-26 | Scras | Dual inhibitors of no synthase and cyclooxygenase |
US5929063A (en) * | 1995-03-24 | 1999-07-27 | Children's Hospital Medical Center | Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
-
1997
- 1997-03-03 WO PCT/US1997/003279 patent/WO1997032575A1/en active Application Filing
- 1997-03-03 AU AU20633/97A patent/AU2063397A/en not_active Abandoned
- 1997-03-03 TR TR1998/01731T patent/TR199801731T2/xx unknown
- 1997-03-03 JP JP9531871A patent/JP2000506852A/ja active Pending
- 1997-03-03 BR BR9707953-7A patent/BR9707953A/pt not_active Application Discontinuation
- 1997-03-03 CN CN97192848A patent/CN1212620A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1212620A (zh) | 1999-03-31 |
AU2063397A (en) | 1997-09-22 |
WO1997032575A1 (en) | 1997-09-12 |
JP2000506852A (ja) | 2000-06-06 |
TR199801731T2 (xx) | 1999-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213129A (pt) | Pró-drogas de compostos policìclicos substituìdos, úteis para inibição seletiva da cascata da coagulação | |
ES2186811T3 (es) | Derivados de feniltiazol con propiedades anti-virus herpes. | |
BR9809115A (pt) | Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt | |
BRPI0413152A (pt) | derivados de benzimidazol alquilado por n3 como inibidores de mek | |
BR9804352A (pt) | Composição e processo para controlar o crescimento microbiológico. | |
HUP9900655A1 (hu) | Eljárás a bőr fényöregedésének gátlására | |
BR0308222A (pt) | Terapias de combinação para tratar células deficientes em metiltioadenosina fosforilase | |
DE69420068T2 (de) | 1H-Indol-3-Acetamid-Derivate als sPLA2-Inhibitoren | |
BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
BR0316883A (pt) | Derivado de piridazin-3(2h)-ona, composto, processo para a preparação de um composto composição farmacêutica, uso do composto, método para o tratamento de um sujeito que está sofrendo de uma condição patológica ou doença susceptìvel de melhora por meio de inibição da fosfodiesterase 4 e produto de combinação | |
BR0309664A (pt) | Derivados de [1,4]diazepino[6,7,1-ij]quinolina como agentes anti-psicóticos e antiobesidade | |
SV2009003227A (es) | Composiciones de inhibidores de chk 1 ref. x-17672 | |
BR0307960A (pt) | N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv | |
BR0315662A (pt) | Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona | |
BR9707953A (pt) | Derivados de mercapto como inibidores de ciclooxigenases | |
BR9607951A (pt) | Derivados de mercapto e seleno como inibidores de sintase de óxido nítrico | |
DK1102781T3 (da) | Nye cofaktorer for methyltransferaser | |
EA199901043A1 (ru) | ИНГИБИТОРЫ ФАРНЕЗИЛТРАНСФЕРАЗЫ В КОМБИНАЦИИ С ИНГИБИТОРАМИ HMG-CoA-РЕДУКТАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА | |
BR0014314A (pt) | Processo para derivados de ácido fenilacético | |
ES2192263T3 (es) | Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas. | |
BR9912870A (pt) | Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas | |
BR0108087A (pt) | Método e composições para o tratamento de uma doença inflamatória | |
BR0015082A (pt) | Derivado de ácido hidroxâmico como inibidor da formação de cd 23 humano solúvel | |
AR002749A1 (es) | Derivados de estiril bencimidazol y composicion farmaceutica que los comprende. | |
BR0113175A (pt) | Derivados da quinolina como agentes antiinflamação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |